Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqGS - Delayed Quote USD

scPharmaceuticals Inc. (SCPH)

Compare
2.3200
+0.3050
+(15.14%)
At close: April 11 at 4:00:01 PM EDT
2.3000
-0.02
(-0.86%)
After hours: April 11 at 4:52:58 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
36,332
36,332
13,593
--
--
Cost of Revenue
11,361
11,361
3,811
--
--
Gross Profit
24,971
24,971
9,782
--
--
Operating Expense
89,747
89,747
65,178
36,157
25,823
Operating Income
-64,776
-64,776
-55,396
-36,157
-25,823
Net Non Operating Interest Income Expense
-4,126
-4,126
-3,019
-2,099
-2,526
Other Income Expense
-16,246
-16,246
3,605
1,418
315
Pretax Income
-85,148
-85,148
-54,810
-36,838
-28,034
Net Income Common Stockholders
-85,148
-85,148
-54,810
-36,838
-28,034
Diluted NI Available to Com Stockholders
-85,148
-85,148
-54,810
-36,838
-28,034
Basic EPS
-1.95
-1.91
-1.42
-1.30
-1.02
Diluted EPS
-1.95
-1.91
-1.42
-1.30
-1.02
Basic Average Shares
40,835.1780
44,519.6690
38,513.7470
28,358.5020
27,351.7300
Diluted Average Shares
40,835.1780
44,519.6690
38,513.7470
28,358.5020
27,351.7300
Total Operating Income as Reported
-64,776
-64,776
-55,396
-36,157
-25,823
Total Expenses
101,108
101,108
68,989
36,157
25,823
Net Income from Continuing & Discontinued Operation
-85,148
-85,148
-54,810
-36,838
-28,034
Normalized Income
-72,116
-72,116
-54,810
-36,838
-28,034
Interest Income
3,444
3,444
5,104
1,203
49
Interest Expense
7,570
7,570
8,123
3,302
2,575
Net Interest Income
-4,126
-4,126
-3,019
-2,099
-2,526
EBIT
-77,578
-77,578
-46,687
-33,536
-25,459
EBITDA
-77,558
-77,558
-46,663
-33,068
-25,021
Reconciled Cost of Revenue
11,361
11,361
3,811
--
--
Reconciled Depreciation
20
20
24
468
438
Net Income from Continuing Operation Net Minority Interest
-85,148
-85,148
-54,810
-36,838
-28,034
Total Unusual Items Excluding Goodwill
-13,032
-13,032
--
--
--
Total Unusual Items
-13,032
-13,032
--
--
--
Normalized EBITDA
-64,526
-64,526
-46,663
-33,068
-25,021
12/31/2021 - 11/17/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

MIST Milestone Pharmaceuticals Inc.
0.7713
+2.84%
 
FENC Fennec Pharmaceuticals Inc.
5.01
0.00%
 
VTYX Ventyx Biosciences, Inc.
0.9685
+4.35%
 
MCRB Seres Therapeutics, Inc.
0.5905
+1.71%
 
ABEO Abeona Therapeutics Inc.
4.6000
+10.05%
 
KZR Kezar Life Sciences, Inc.
3.9500
0.00%
 
RZLT Rezolute, Inc.
2.4700
0.00%
 
ATYR aTyr Pharma, Inc.
2.9700
+8.39%
 
VIGL Vigil Neuroscience, Inc.
1.4900
-2.61%
 
ATRA Atara Biotherapeutics, Inc.
5.53
+4.34%